The PubMed record describes a comparative study titled: "Oncological Outcomes and Prognostic Factors of Platinum-Based Chemotherapy Followed by Avelumab Maintenance Therapy Compared With Platinum-Based Chemotherapy Alone: A Propensity Score-Matched Analysis in a Real-World Population." The citation in the source lists Int J Urol. 2026 Aug;33(8):e70584 with DOI 10.1111/iju.70584 and PubMed ID 42533764.
The entry identifies the study as a real-world, propensity score-matched comparison of treatment strategies that include platinum-based chemotherapy with or without subsequent avelumab maintenance therapy. Beyond the title and bibliographic details, the provided PubMed content does not include the article abstract or the study's numerical outcomes in the excerpt available here.
The published record lists Yuto Matsushita as first author and includes many coauthors. Affiliations are provided for 16 institutions across Japan, indicating a multicenter contribution. The listed affiliations span academic departments of urology and regional hospitals and include involvement from the Japanese Urological Oncology Group. The PubMed metadata in the source is limited to author names, institutional affiliations, and the corporate author listing; institutional locations and exact roles are those shown in the source.
According to the bibliographic record, the study compares oncological outcomes and prognostic factors between two treatment approaches in a real-world population, using a propensity score-matched analytic approach. The title specifies the two comparator arms: platinum-based chemotherapy followed by avelumab maintenance versus platinum-based chemotherapy alone.
The source material available here does not contain the full abstract text or the manuscript content; therefore, the PubMed entry communicates only the study aim and design as stated in the title and indexing fields. No further methodological details (for example, matching variables, timing of maintenance, or follow-up schedule) are present in the provided content.
The PubMed page content provided in this record does not include key trial details and outcomes. Specifically, the following items were not reported in the source excerpt:
These omissions reflect the limits of the PubMed abstract display captured in the source. The full text or the complete abstract on the publisher or PubMed web page would be required to access these data.
The study title indicates relevance to clinicians considering maintenance therapy with avelumab after platinum-based chemotherapy in a real-world context. Because the source record demonstrates a propensity score-matched comparative approach and multicenter Japanese participation, the study likely aims to address comparative effectiveness and prognostic factors encountered in routine practice rather than in a randomized controlled trial setting. However, outcome data, effect sizes, and safety information necessary to judge clinical impact are not available in the provided record.
Clinicians and researchers interested in the study's findings should obtain and review the full article to evaluate: study population characteristics; matching methodology; primary and secondary endpoints; numerical results and measures of effect; adverse events; subgroup analyses; and the authors' stated limitations and conclusions.
The PubMed entry provides the DOI (10.1111/iju.70584) and PMID (42533764) and identifies the journal (International Journal of Urology) and issue (2026 Aug;33(8):e70584). Use these identifiers to retrieve the full abstract or full-text article from the journal publisher's website, PubMed's abstract display, institutional library resources, or other bibliographic databases. The PubMed page shown here contains author and affiliation metadata but does not include the complete abstract or the manuscript text; accessing the publisher record or the article PDF is required to review study methods and results.
Note on source limitations
This rewritten summary uses only the bibliographic and author-affiliation information present in the supplied PubMed record. Specific numerical results, statistical findings, safety data, and detailed methods were not included in the source content and therefore are not reported here. For clinical decision-making or citation, consult the full published article.